A detailed history of Exchange Traded Concepts, LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 212,638 shares of KPTI stock, worth $176,489. This represents 0.01% of its overall portfolio holdings.

Number of Shares
212,638
Previous 115,864 83.52%
Holding current value
$176,489
Previous $99,000 224.24%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$0.72 - $1.66 $69,677 - $160,644
96,774 Added 83.52%
212,638 $321,000
Q4 2023

Jan 05, 2024

BUY
$0.68 - $1.31 $19,978 - $38,487
29,380 Added 33.97%
115,864 $99,000
Q3 2023

Oct 18, 2023

BUY
$1.14 - $1.81 $22,870 - $36,312
20,062 Added 30.2%
86,484 $115,000
Q2 2023

Jul 20, 2023

BUY
$1.79 - $4.59 $118,895 - $304,876
66,422 New
66,422 $118,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $66.2M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.